Abstract
This article covers procedures for transitioning to the common market of the Eurasian Economic Union (EAEU), with a focus on low-margin yet high-demand medicines, including herbal medicinal products. First, the article analyses applicant engagement in aligning the dossiers for nationally authorised medicinal products with the requirements of the EAEU authorisation procedures. Then, the article describes the legislative changes introduced to ease authorisation requirements. Finally, the author provides recommendations for applicants.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
